Flattening the curve of prostate cancer progression: accurate detection and safe ablation
Affiliation
Knight Cancer Institute, Department of Radiation Medicine, Oregon Health and Science University, Portland, Oregon.Issue Date
2020
Metadata
Show full item recordCitation
Mitin T, Choudhury A. Flattening the Curve of Prostate Cancer Progression: Accurate Detection and Safe Ablation. Int J Radiat Oncol Biol Phys. 2020;107(4):609-12.Journal
International Journal of Radiation Oncology Biology PhysicsDOI
10.1016/j.ijrobp.2020.04.028PubMed ID
32589984Additional Links
https://dx.doi.org/10.1016/j.ijrobp.2020.04.028Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.ijrobp.2020.04.028
Scopus Count
Collections
Related articles
- A Prospective Comparison of (18)F-prostate-specific Membrane Antigen-1007 Positron Emission Tomography Computed Tomography, Whole-body 1.5 T Magnetic Resonance Imaging with Diffusion-weighted Imaging, and Single-photon Emission Computed Tomography/Computed Tomography with Traditional Imaging in Primary Distant Metastasis Staging of Prostate Cancer (PROSTAGE).
- Authors: Anttinen M, Ettala O, Malaspina S, Jambor I, Sandell M, Kajander S, Rinta-Kiikka I, Schildt J, Saukko E, Rautio P, Timonen KL, Matikainen T, Noponen T, Saunavaara J, Löyttyniemi E, Taimen P, Kemppainen J, Dean PB, Blanco Sequeiros R, Aronen HJ, Seppänen M, Boström PJ
- Issue date: 2021 Aug
- Optimal Timing of Prostate Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography for Biochemical Recurrence after Radical Prostatectomy.
- Authors: Luiting HB, van Leeuwen PJ, Remmers S, Donswijk M, Busstra MB, Bakker IL, Brabander T, Stokkel M, van der Poel HG, Roobol MJ
- Issue date: 2020 Sep
- Clinical Relevance of Incidental Prostatic Lesions on FDG-Positron Emission Tomography/Computerized Tomography-Should Patients Receive Further Evaluation?
- Authors: Reesink DJ, Fransen van de Putte EE, Vegt E, De Jong J, van Werkhoven E, Mertens LS, Bex A, van der Poel HG, van Rhijn BW, Horenblas S, Meijer RP
- Issue date: 2016 Apr
- Prostate Specific Membrane Antigen Targeted (18)F-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk Prostate Cancer: Results of a Prospective, Phase II, Single Center Study.
- Authors: Gorin MA, Rowe SP, Patel HD, Vidal I, Mana-Ay M, Javadi MS, Solnes LB, Ross AE, Schaeffer EM, Bivalacqua TJ, Partin AW, Pienta KJ, Szabo Z, De Marzo AM, Pomper MG, Allaf ME
- Issue date: 2018 Jan
- How does (68) Ga-prostate-specific membrane antigen positron emission tomography/computed tomography impact the management of patients with prostate cancer recurrence after surgery?
- Authors: Bianchi L, Schiavina R, Borghesi M, Ceci F, Angiolini A, Chessa F, Droghetti M, Bertaccini A, Manferrari F, Marcelli E, Cochetti G, Porreca A, Castellucci P, Fanti S, Brunocilla E
- Issue date: 2019 Aug